-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Approves Renewal Of Canalevia-CA1

Benzinga·12/10/2025 14:05:42
Listen to the news

Conditional approval extended through December 2026 for the treatment of CID in dogs

CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA's June deadline - 51 dogs enrolled to date; ~49 more expected